Trial intelligence / Profile preview

Pioglitazone and Atorvastatin for Intima-Media Thickness

NCT00770575Phase 2Completed

Sponsor
Takeda
Start
Jun 2005
Primary completion
Oct 2006
Modality
Small Molecules
01

Overview

A Phase 2 trial of pioglitazone in cardiovascular disease (CVD), sponsored by Takeda. Started Jun 2005; status: completed.

02

Drugs

pioglitazone
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00770575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00770575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call